← back to search

Douglas E. V. Pires

The University of Melbourne · AU
Area of research
Molecular Biology · Computational Theory and Mathematics
Research interest
Research interests include Protein Structure and Dynamics, Computational Drug Discovery Methods, Bioinformatics and Genomic Networks, and RNA and protein synthesis mechanisms.
h-index
45
citations
13,990
works
134
NIH funding
primary concept
email

Recent publications

Computational design of therapeutic antibodies with improved developability: efficient traversal of binder landscapes and rescue of escape mutations
mAbs 2025cited by 9position: middledoi
A structural biology community assessment of AlphaFold2 applications
Nature Structural & Molecular Biology 2022cited by 700position: middledoi
<scp>DynaMut2</scp>: Assessing changes in stability and flexibility upon single and multiple point missense mutations
Protein Science 2020cited by 638position: middledoi
Prediction of rifampicin resistance beyond the RRDR using structure-based machine learning approaches
Scientific Reports 2020cited by 55position: middledoi
DynaMut: predicting the impact of mutations on protein conformation, flexibility and stability
Nucleic Acids Research 2018cited by 1,127position: middledoi
Tumour risks and genotype–phenotype correlations associated with germline variants in succinate dehydrogenase subunit genes <i>SDHB</i>, <i>SDHC</i> and <i>SDHD</i>
Journal of Medical Genetics 2018cited by 250position: middledoi
Familial STAG2 germline mutation defines a new human cohesinopathy
npj Genomic Medicine 2017cited by 68position: middledoi
Mycobacterium tuberculosis whole genome sequencing and protein structure modelling provides insights into anti-tuberculosis drug resistance
BMC Medicine 2016cited by 113position: middledoi
Germline Mutations in the<i>CDKN2B</i>Tumor Suppressor Gene Predispose to Renal Cell Carcinoma
Cancer Discovery 2015cited by 92position: middledoi
mCSM: predicting the effects of mutations in proteins using graph-based signatures
Bioinformatics 2013cited by 1,095position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

David B. Ascher · Baker Heart and Diabetes Institute7 papers (2013–2020)Tom L. Blundell · University of Cambridge2 papers (2013–2015)Carlos H. M. Rodrigues · Australian Centre for Disease Preparedness2 papers (2018–2020)Farida Latif · Dow University of Health Sciences1 papers (2015–2015)Heloísa B. Pena · Gene Therapy Laboratory1 papers (2017–2017)Yoochan Myung · University of Queensland1 papers (2020–2020) · 1 papers (2025–2025) · 1 papers (2025–2025)Stephanie Portelli · London School of Hygiene & Tropical Medicine1 papers (2020–2020)Francesc Coll · London School of Hygiene & Tropical Medicine1 papers (2016–2016)Natália D. Linhares · University Hospital Heidelberg1 papers (2017–2017) · 1 papers (2025–2025) · 1 papers (2017–2017)Carolina Cavaliéri Gomes · McGill University1 papers (2017–2017) · 1 papers (2017–2017)John F. Darby · University of York1 papers (2025–2025) · 1 papers (2025–2025)Ruth McNerney · London School of Hygiene & Tropical Medicine1 papers (2016–2016)Alan Donaldson · St Michael's Hospital1 papers (2015–2015)Andrew Ramsay · Indiana University School of Medicine1 papers (2016–2016)